Insider Transactions in Q3 2024 at Neumora Therapeutics, Inc. (NMRA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
10,676
-3.15%
|
$128,112
$12.09 P/Share
|
|
Sep 17
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
30,788
-8.32%
|
$338,668
$11.81 P/Share
|
|
Sep 12
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
32,948
-8.18%
|
$362,428
$11.43 P/Share
|
|
Aug 27
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
15,693
-10.15%
|
$172,623
$11.39 P/Share
|
|
Aug 26
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
31,642
-16.98%
|
$348,062
$11.78 P/Share
|
|
Aug 23
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,169
-11.48%
|
$265,859
$11.59 P/Share
|
|
Aug 22
2024
|
Joshua Pinto Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
28,496
-11.92%
|
$313,456
$11.63 P/Share
|